Phreesia, Inc. (NYSE:PHR) CFO Sells $191,873.25 in Stock

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 8,045 shares of the firm’s stock in a transaction dated Tuesday, April 8th. The shares were sold at an average price of $23.85, for a total transaction of $191,873.25. Following the transaction, the chief financial officer now owns 108,411 shares of the company’s stock, valued at $2,585,602.35. This trade represents a 6.91 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Balaji Gandhi also recently made the following trade(s):

• On Wednesday, March 26th, Balaji Gandhi sold 1,827 shares of Phreesia stock. The stock was sold at an average price of $27.46, for a total value of $50,169.42.
• On Tuesday, February 18th, Balaji Gandhi sold 5,771 shares of Phreesia stock. The stock was sold at an average price of $30.04, for a total transaction of $173,360.84.
• On Thursday, February 13th, Balaji Gandhi sold 28,759 shares of Phreesia stock. The shares were sold at an average price of $30.00, for a total value of $862,770.00.
• On Monday, January 27th, Balaji Gandhi sold 4,813 shares of Phreesia stock. The stock was sold at an average price of $27.48, for a total transaction of $132,261.24.
• On Tuesday, January 21st, Balaji Gandhi sold 5,827 shares of Phreesia stock. The stock was sold at an average price of $27.31, for a total value of $159,135.37.
• On Wednesday, January 15th, Balaji Gandhi sold 836 shares of Phreesia stock. The shares were sold at an average price of $26.98, for a total transaction of $22,555.28.

Phreesia Stock Up 0.3 %

PHR opened at $24.06 on Friday. The stock’s fifty day moving average is $26.57 and its 200-day moving average is $24.26. The company has a market capitalization of $1.41 billion, a PE ratio of -16.37 and a beta of 0.82. Phreesia, Inc. has a one year low of $17.07 and a one year high of $30.53. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74.

Hedge Funds Weigh In On Phreesia

Large investors have recently made changes to their positions in the business. Deerfield Management Company L.P. Series C grew its holdings in shares of Phreesia by 133.6% in the 4th quarter. Deerfield Management Company L.P. Series C now owns 1,271,832 shares of the company’s stock worth $31,999,000 after acquiring an additional 727,384 shares during the last quarter. Greenhouse Funds LLLP increased its position in Phreesia by 27.9% in the 4th quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company’s stock worth $72,307,000 after purchasing an additional 626,579 shares during the last quarter. Park West Asset Management LLC bought a new position in Phreesia during the fourth quarter valued at approximately $10,657,000. Millennium Management LLC raised its holdings in shares of Phreesia by 83.2% during the 4th quarter. Millennium Management LLC now owns 653,634 shares of the company’s stock valued at $16,445,000 after purchasing an additional 296,863 shares in the last quarter. Finally, ExodusPoint Capital Management LP raised its holdings in Phreesia by 448.6% during the fourth quarter. ExodusPoint Capital Management LP now owns 174,971 shares of the company’s stock valued at $4,402,000 after buying an additional 143,077 shares in the last quarter. Institutional investors own 92.10% of the company’s stock.

Wall Street Analysts Forecast Growth

PHR has been the topic of several analyst reports. Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and raised their target price for the company from $24.00 to $32.00 in a report on Wednesday, January 8th. Piper Sandler reaffirmed an “overweight” rating and set a $33.00 price target (up previously from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. Needham & Company LLC reaffirmed a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a report on Thursday, March 13th. Citigroup lifted their target price on Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research note on Friday, January 10th. Finally, KeyCorp upped their price target on shares of Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 8th. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat, Phreesia currently has a consensus rating of “Buy” and an average price target of $31.33.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.